Article
PRL phosphatases as potential molecular targets in cancer
1 Nov 2005
Abstract excerpt
The phosphatase of regenerating liver (PRL) family of phosphatases, consisting of PRL-1, PRL-2, and PRL-3, represents an intriguing group of proteins being validated as biomarkers and therapeutic targets in cancer. Individual PRLs are overexpressed in a variety of cancer cell lines and tissues when compared with their normal counterparts. More importantly, several recent studies have shown that PRL-3 is expressed...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
